Emerging technologies and commercial products in exosome-based cancer diagnosis and prognosis

M Mohammadi, H Zargartalebi, R Salahandish… - Biosensors and …, 2021 - Elsevier
Academic and industrial groups worldwide have reported technological advances in
exosome-based cancer diagnosis and prognosis. However, the potential translation of these …

Engineered biosensors for diagnosing multidrug resistance in microbial and malignant cells

NG Jha, DS Dkhar, SK Singh, SJ Malode, NP Shetti… - Biosensors, 2023 - mdpi.com
To curtail pathogens or tumors, antimicrobial or antineoplastic drugs have been developed.
These drugs target microbial/cancer growth and survival, thereby improving the host's …

Emerging roles and biopharmaceutical applications of milk derived exosomes

N Desai, A Gadeval, U Kathar, P Sengupta… - Journal of Drug Delivery …, 2021 - Elsevier
Exosomes are bilayer nanovesicles of endocytic origin engaged in intercellular
communication through functionally active and cell-specific cargo (such as proteins, lipids …

[HTML][HTML] Exosomes as versatile nanoscaled biocompartments in cancer therapy and/or resistance

YR Saadat, J Barar - BioImpacts: BI, 2022 - ncbi.nlm.nih.gov
Cancer remains to be a major hurdle to global health. Exosomes as a versatile bio-derived
platform, hold a bright prospect in nano-scaled delivery/targeting strategies. Shreds of …

FORMULATION AND CHARACTERIZATION OF SACITUZUMAB-LOADED CHITOSAN NANOPARTICLES VIA IONOTROPIC GELATION FOR ENHANCED DRUG …

UK Sharma, S Mandal, SS Patil… - Bulletin of Pure and …, 2024 - bpasjournals.com
Sacituzumab loaded chitosan nanoparticles were produced by the ionotropic gelation
method. This method exploits the electrostatic interaction between the negatively charged …

Evaluate the Biological Consequences and the Effect of Extracellular Vesicle Release Inhibition of Anti-SNARE Loaded Liposomes on Drug Resistance Triple …

H Li - 2023 - search.proquest.com
Abstract Triple Negative Breast Cancer (TNBC) is the most aggressive subtype with high
heterogeneity and recurrence rate. It's characterized by multidrug resistance (MDR), which …

[引用][C] Editorial overview: New technologies in 2020: Drug resistance

VKW Wong - Current opinion in pharmacology, 2020 - pubmed.ncbi.nlm.nih.gov
Editorial overview: New technologies in 2020: Drug resistance Editorial overview: New
technologies in 2020: Drug resistance Curr Opin Pharmacol. 2020 Oct:54:iii-vi. doi: 10.1016/j.coph.2020.12.002 …